LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $689 | -3.5% | 8 | 0.0% | 0.00% | – |
| Q2 2022 | $714 | -20.7% | 8 | 0.0% | 0.00% | – |
| Q1 2022 | $900 | -27.2% | 8 | 0.0% | 0.00% | – |
| Q4 2021 | $1,236 | +10.9% | 8 | 0.0% | 0.00% | – |
| Q3 2021 | $1,115 | +6.2% | 8 | 0.0% | 0.00% | – |
| Q2 2021 | $1,050 | -13.9% | 8 | 0.0% | 0.00% | – |
| Q1 2021 | $1,220 | +53.3% | 8 | 0.0% | 0.00% | – |
| Q4 2020 | $796 | -88.6% | 8 | -89.0% | 0.00% | – |
| Q3 2020 | $6,958 | -14.8% | 73 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $8,165 | +53.8% | 73 | 0.0% | 0.00% | – |
| Q1 2020 | $5,309 | -17.9% | 73 | +17.7% | 0.00% | – |
| Q4 2019 | $6,466 | +4.8% | 62 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $6,171 | +8.1% | 62 | +24.0% | 0.00% | – |
| Q2 2019 | $5,708 | -31.2% | 50 | -24.2% | 0.00% | -100.0% |
| Q1 2019 | $8,297 | -28.1% | 66 | -22.4% | 0.00% | 0.0% |
| Q4 2018 | $11,535 | -2.3% | 85 | +97.7% | 0.00% | 0.0% |
| Q3 2018 | $11,803 | -1.8% | 43 | -25.9% | 0.00% | -50.0% |
| Q2 2018 | $12,016 | +25.4% | 58 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $9,579 | +20.6% | 58 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,942 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |